Clinical Trials Arena reports that MHRA has issued a strategy looking ahead to 2030 for medicines and medical devices. The plan includes AI among technologies intended to improve regulatory efficiency and put greater focus on patients.
Regulations and guidanceData, digital and AIAI summary
Read at Clinical Trials Arena